Novadip Biosciences raised €40M in a Series B round in Nov 2022. The company is based in Ottignies-Louvain-la-Neuve, Belgium. Investors in the round: Pierre Drion, CR-CP Life Science Fund, Fund plus and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €40M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
